These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18036819)

  • 1. Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuroectodermal tumour: analysis of the VETOPEC regimen.
    White L; Sterling-Levis K
    J Clin Neurosci; 2008 Jan; 15(1):49-54. PubMed ID: 18036819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.
    Ziegler DS; Cohn RJ; McCowage G; Alvaro F; Oswald C; Mrongovius R; White L;
    Neuro Oncol; 2006 Jan; 8(1):53-9. PubMed ID: 16443948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model.
    White L; Sterling-Levis K; Kees UR; Tobias V
    J Clin Neurosci; 2001 Mar; 8(2):151-6. PubMed ID: 11484666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).
    White L; Kellie S; Gray E; Toogood I; Waters K; Lockwood L; Macfarlane S; Johnston H
    J Pediatr Hematol Oncol; 1998; 20(2):125-30. PubMed ID: 9544162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
    Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
    Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group study.
    McCowage GB; Mrongovius R; Alvaro F; Cohn RJ; Ziegler DS; Oswald C; White L;
    Pediatr Blood Cancer; 2011 Dec; 57(6):958-64. PubMed ID: 21793175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
    Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
    Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of xenografting in pediatric brain tumor research with specific emphasis on medulloblastoma/primitive neuroectodermal tumors of childhood.
    Sterling-Levis K; White L
    In Vivo; 2003; 17(4):329-42. PubMed ID: 12929588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
    Leggas M; Stewart CF; Woo MH; Fouladi M; Cheshire PJ; Peterson JK; Friedman HS; Billups C; Houghton PJ
    Clin Cancer Res; 2002 Sep; 8(9):3000-7. PubMed ID: 12231547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE; Strongin IuS; Talabaev MV; Aleĭnikova OV
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
    Meco D; Di Francesco AM; Cusano G; Bucci F; Pierri F; Patriarca V; Torella AR; Pisano C; Riccardi R
    Cancer Chemother Pharmacol; 2012 Dec; 70(6):811-22. PubMed ID: 23007316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meningoradiculitis revealing an occult medulloblastoma-PNET in an adult].
    Alla P; de Jauréguiberry JP; Carloz E; Gisserot O; Valance J; Jaubert D
    Rev Neurol (Paris); 1998 Jul; 154(6-7):542-5. PubMed ID: 9773089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
    Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
    J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
    Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
    Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Gajjar A; Pizer B
    Pediatr Blood Cancer; 2010 Apr; 54(4):649-51. PubMed ID: 20146223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group.
    White L; McCowage G; Kannourakis G; Nayanar V; Colnan L; Kellie S; Shaw P; Seshadri R; Lockwood L; Tiedemann K
    J Clin Oncol; 1994 Mar; 12(3):522-31. PubMed ID: 8120550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.